News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
46,075 Results
Type
Article (3586)
Company Profile (28)
Press Release (42461)
Section
Business (14052)
Career Advice (55)
Deals (1773)
Drug Delivery (7)
Drug Development (3815)
Employer Resources (3)
FDA (586)
Job Trends (1251)
News (19859)
Policy (1347)
Tag
Academia (430)
Accelerated approval (4)
Allergies (7)
Alliances (5610)
ALS (13)
Alzheimer's disease (76)
Antibody-drug conjugate (ADC) (13)
Approvals (599)
Artificial intelligence (82)
Autoimmune disease (6)
Automation (11)
Bankruptcy (14)
Best Places to Work (1103)
BIOSECURE Act (12)
Biosimilars (1)
Biotechnology (24)
Bladder cancer (12)
Brain cancer (6)
Breast cancer (107)
Cancer (585)
Cardiovascular disease (15)
Career advice (56)
Career pathing (2)
CAR-T (25)
Celiac Disease (1)
Cell therapy (83)
Cervical cancer (1)
Clinical research (2817)
Collaboration (231)
Compensation (23)
Complete response letters (2)
COVID-19 (204)
CRISPR (42)
C-suite (61)
Cystic fibrosis (9)
Data (482)
Depression (2)
Diabetes (21)
Diagnostics (1474)
Digital health (2)
Diversity, equity & inclusion (1)
Drug discovery (23)
Drug pricing (1)
Duchenne muscular dystrophy (13)
Earnings (3533)
Editorial (1)
Employer branding (1)
Employer resources (3)
Events (6658)
Executive appointments (85)
FDA (721)
Friedreich's ataxia (1)
Funding (99)
Gene editing (97)
Generative AI (5)
Gene therapy (89)
GLP-1 (36)
Government (295)
Guidances (23)
Healthcare (1224)
HIV (2)
Huntington's disease (4)
IgA nephropathy (1)
Immunology and inflammation (4)
Immuno-oncology (6)
Indications (8)
Infectious disease (217)
Inflammatory bowel disease (10)
Influenza (7)
Intellectual property (13)
Interviews (4)
IPO (776)
Job creations (179)
Job search strategy (52)
JPM (2)
Labor market (3)
Layoffs (18)
Legal (209)
Liver cancer (9)
Longevity (2)
Lung cancer (99)
Lymphoma (23)
Machine learning (8)
Management (1)
Manufacturing (47)
MASH (5)
Medical device (338)
Medtech (340)
Mergers & acquisitions (1051)
Metabolic disorders (37)
Multiple sclerosis (2)
NASH (1)
Neurodegenerative disease (21)
Neuropsychiatric disorders (1)
Neuroscience (137)
NextGen: Class of 2026 (384)
Non-profit (296)
Now hiring (4)
Obesity (9)
Opinion (30)
Ovarian cancer (8)
Pain (12)
Pancreatic cancer (24)
Parkinson's disease (15)
Partnered (1)
Patents (22)
Patient recruitment (17)
Peanut (5)
People (4543)
Pharmaceutical (2)
Phase 1 (1235)
Phase 2 (1334)
Phase 3 (861)
Pipeline (305)
Policy (18)
Postmarket research (42)
Preclinical (698)
Press Release (22)
Prostate cancer (20)
Radiopharmaceuticals (3)
Rare diseases (83)
Real estate (353)
Regulatory (1045)
Reports (3)
Research institute (524)
Resumes & cover letters (2)
Rett syndrome (6)
RSV (2)
Schizophrenia (4)
Series A (22)
Series B (14)
Sickle cell disease (24)
Spinal muscular atrophy (2)
Sponsored (2)
Startups (363)
Supply chain (6)
Vaccines (28)
Venture capital (4)
Weight loss (4)
Date
Last 7 days (29)
Last 30 days (136)
Last 365 days (1845)
2026 (181)
2025 (1919)
2024 (2786)
2023 (3244)
2022 (4361)
2021 (4534)
2020 (3868)
2019 (2933)
2018 (2187)
2017 (2507)
2016 (2406)
2015 (2488)
2014 (1610)
2013 (1393)
2012 (1416)
2011 (1401)
2010 (1236)
Location
Africa (59)
Alabama (9)
Alaska (1)
Arizona (22)
Asia (2332)
Australia (358)
California (1048)
Canada (130)
China (72)
Colorado (23)
Connecticut (48)
Delaware (12)
Europe (5958)
Florida (96)
Georgia (4)
Hawaii (2)
Idaho (1)
Illinois (32)
India (4)
Indiana (12)
Iowa (8)
Japan (31)
Kansas (4)
Kentucky (2)
Louisiana (3)
Maine (4)
Maryland (112)
Massachusetts (636)
Michigan (14)
Minnesota (21)
Mississippi (1)
Missouri (10)
Montana (2)
Nebraska (5)
Nevada (6)
New Hampshire (3)
New Jersey (132)
New Mexico (11)
New York (153)
North Carolina (169)
North Dakota (7)
Northern California (488)
Ohio (22)
Oregon (3)
Pennsylvania (77)
Rhode Island (3)
South America (59)
South Carolina (3)
Southern California (409)
Tennessee (5)
Texas (202)
United States (2939)
Utah (37)
Virginia (11)
Washington D.C. (4)
Washington State (53)
Wisconsin (21)
46,075 Results for "cofactor genomics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cofactor Genomics Advances Predictive Cancer Diagnostics With Landmark OncoPrism-NSCLC Study
December 18, 2025
·
3 min read
Press Releases
Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks
December 16, 2025
·
4 min read
Press Releases
Cofactor Genomics Announces the Expansion of OncoPrism into Colorectal, Breast, Bladder, and Kidney Cancer
March 6, 2025
·
3 min read
Press Releases
Cofactor Genomics Presents Breakthrough Work Combining RNA and AI to bring Precision Medicine to Immunotherapy at RNA Society’s 30th Annual Meeting
May 30, 2025
·
3 min read
Press Releases
Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics’ Advisory Board as Cofactor Brings OncoPrism test to Partnered Hospitals
October 29, 2024
·
2 min read
Business
Stanford University Joins Cofactor Genomics’ Clinical Trial Evaluating Immunotherapy Predictive Diagnostic Assay Across 11 Cancers
Stanford University and Cofactor Genomics, the company bridging the precision medicine gap, announced that Stanford will join Cofactor’s PREDAPT clinical trial evaluating use of the company’s OncoPrism™ predictive diagnostic assay across 11 cancers.
July 11, 2023
·
2 min read
BioMidwest
Cofactor Genomics’ Immunotherapy Predictive Diagnostic, OncoPrism, Completes Validation and Moves Into Clinical Use in Head and Neck Cancer Patients
Cofactor Genomics, the company bridging the precision medicine gap, today announced successful validation of the OncoPrism immunotherapy predictive diagnostic assay, enabling physicians to use the test to help guide treatment decisions for patients with metastatic or recurrent squamous cell carcinoma of the head and neck (HNSCC).
November 17, 2023
·
2 min read
Press Releases
Cofactor Genomics Publishes Clinical Validation of OncoPrism-HNSCC, a Test Leveraging Novel RNA Modeling Technology to Predict Response to Immunotherapy
November 7, 2024
·
2 min read
Press Releases
Cofactor Genomics receives Medicare coverage for OncoPrism®, a machine learning-based RNA oncology test predicting immunotherapy response
October 21, 2024
·
1 min read
Business
Culmination Bio and Cofactor Genomics Leverage Largest Biobank in the U.S. for PREDAPT Precision Medicine Clinical Trial
Culmination Bio today announced a partnership to leverage samples and data from one of the largest biobanks in the country to fuel the development of Cofactor Genomic’s OncoPrism™ test in 11 cancers.
May 9, 2023
·
3 min read
1 of 4,608
Next
